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ABSTRACT
Background: Bovine mastitis, a global disease that is responsible for large economic losses each year due to lower milk 
yield and reduced milk quality. In some countries, especially in China, Streptococcus agalactiae has become one of the 
most frequently detected pathogen. Antibiotic treatment and vaccine immunization are important strategies for the control 
of infectious diseases. The main objective of the present study was to evaluate distribution of bovine mastitis pathogens 
and antimicrobial resistance of S. agalactiae, and contribute to the treatment of bovine mastitis.
Materials, Methods & Results: Clinical mastitis samples (n= 1,122) were collected from 27 dairy farms located in 15 
different provinces of China during 2012-2018. The pathogens were identified by 16S rDNA method. Antimicrobial sus-
ceptibility was assessed by disc diffusion method. Molecular characteristics was distinguished based on PCR. The results 
showed that the main pathogens were Streptococcus agalactiae (n= 324, 26.2%), Escherichia coli (n= 287, 23.2%), and 
Staphylococcus aureus (n= 131, 10.6%). The serotypes of Streptococcus agalactiae were serotype II (53.6%), Ia (44 %) 
and VII (1.2%), respectively. Streptococcus agalactiae were resistant to kanamycin (93.8%), gentamicin (49.4%), vanco-
mycin (49.4%), tetracycline (35.8%), clindamycin (34.6%) and erythromycin (32.1%). The main resistance genes were 
ermA (53.1%) and ermB (85.2%). Resistance to erythromycin was attributed to the genes ermA (P < 0.05) and resistance 
to tetracycline was attributed to the genes tetK, tetM, tetO (P < 0.01). The virulence genes scpB (81.4%), cyl (100%), glnA 
(76.6%), cfb (98.8%), hylB (98.8%), scaA (69.1%) were detected in almost all isolates.
Discussion: In the present study, Streptococcus agalactiae, Escherichia coli and Staphylococcus aureus were the patho-
gens isolated most frequently from clinical mastitis. In the case of S. agalactiae, we performed capsular serotyping of 
isolates. As a result, serotype II (53.6%), Ia (44 %) and VII (1.2%) were detected which revealed variation in the distinct 
geographical areas. We found that serotypes (Ia and II) and β-hemolytic have significant correlation (P < 0.01) in all isolated 
strains. We made an assumption that either in processes of capsular and haemolytic appearance effected the expression of 
another. The unclear mechanism remains to be resolved in the future. Penicillin was recommended as a preferred antibiotic 
for the treatment of both human and bovine S. agalactiae infection. In the present study, resistance to erythromycin and 
clindamycin were observed in 32% and 34.6% of our strains, respectively. The results indicated that the ermB gene was 
most frequent among the erythromycin-resistant S. agalactiae. However, we found that the susceptibility to erythromycin 
and gene ermA have a significant interaction, while susceptibility to erythromycin and gene ermB have a not significant 
interaction by analyzing the relationship of phenotypic and genotypic resistance. The severity of S. agalactiae infections 
may be determined by various virulence factors. Surface enzyme ScpB, a C5a peptidase, encode by scpB gene, could 
promote bacterial invasion of epithelial cells by attenuating recruitment of polymorphonuclear leukocytes to the site of 
infection. In the present study, the scpB gene was found in 81.4% of all strains. The results suggested the cyl, cfb, hylB 
and scpB genes may play an important role in the virulence of Streptococcus agalactiae pathogens.
Keywords: Streptococcus agalactiae, serotypes, antimicrobial resistance, virulence genes.
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INTRODUCTION
Bovine mastitis, a global disease that is re-
sponsible for large economic losses each year due to 
lower milk yield and reduced milk quality [6,15,17,32]. 
Mastitis is complex, developing as a result of inter-
action between various factors associated with the 
host, specific pathogens, environment, and manage-
ment [1,36]. Over 150 different bacteria have been 
recorded to cause bovine mastitis [5,20,33]. In China, 
Streptococcus agalactiae has become one of the most 
frequently detected pathogens [27,35,36].
Bacterial genotyping is one of the key steps in 
the development of an effective and practical vaccine. 
Capsular serotyping is a classical method used for S. aga-
lactiae [4,18]. It is common knowledge that antibiotics 
are among the major tools in combating bovine mastitis. 
However, due to the widespread use of antimicrobial 
compounds, the occurrence of antimicrobial-resistant 
has increased [7,25]. Resistance genes are responsible 
for resistance to erythromycin and tetracycline which 
included ermA, ermB, ermC, mefA, tetK, tetL, tetM, tetO 
and tetS, respectively [7,9,11]. The ability of infections 
may be determined by various virulence genes, such as 
cyl, cfb, hylB, scpB, lmb, bac,  and scaA, which encodes 
for β-hemolysin, Christie-Atkins-Munch-Peterson 
(CAMP), hyaluronidase, surface enzyme ScpB (C5a 
peptidase), laminine-binding protein, β-antigen, aggre-
gation factor, respectively [3,19].
The aim of the present study was to evaluate 
distribution of bovine mastitis pathogens, antimicrobial 
resistance and virulence genes of Streptococcus aga-
lactiae isolated from bovine mastitis cases in China, 
and contribute to the treatment of bovine mastitis.
MATERIALS AND METHODS
Sample collection
A total of 1,122 milk samples were collected 
from 27 commercial dairy farms located in 15 dif-
ferent provinces of China from 2012 to 2018. All 
samples were collected from cows with clinical mastitis 
aseptically as described by Pitkälä et al. [29]. Before 
sampling, first stream of milk were discarded, and the 
teat ends were disinfected with cotton swabs soaked 
in 70% (v/v) alcohol and allowed to dry. Then 5-mL 
secretion was collected into a sterile 10-mL tube. All 
samples were kept at 4°C for microbiological exami-
nation within 18 h.
Bacterial isolation and identification
The samples were enriched in 2 mL nutrient 
broth supplemented with 1% glucose (w/v) and 2% calf 
serum, and incubated at 37oC for 18-24 h. A bacterio-
logical loop was used to spread approximately 0.02 mL 
of each enriched bacteria samples on blood agar1. The 
plates were incubated at 37oC and examined after 24 
h. Typical Streptococcus colonies were distinguished 
microscopically by colony morphology, then by the 
characteristic appearance on hemolysis, and Gram,s 
stain, catalase test and CAMP test, respectively. 
The genomic DNA of strains was extracted 
from overnight cultured isolates using the Bacterial 
DNA Kit2. The purified genomic DNA was stored at 
-20oC until use. The 16S rDNA sequence was amplified 
by Takara 16S rDNA Bacterial Identification PCR Kit3. 
The PCR products were analyzed by electrophoresis 
using 1% agarose gel. By comparing the Biotechnology 
Information (NCBI), bacterial species were identified.
Hemolytic characteristic and capsular serotypes
Strains of Streptococcus agalactiae (n= 81) 
were randomly selected for serotyping, antimicrobial 
susceptibility test and antimicrobial resistance and vir-
ulence genes detection. For hemolytic characteristics 
of S. agalactiae strains, isolates were cultured on blood 
agar plates. Identification of serotypes was performed 
by multiplex PCR assay as described previously [18].
Antimicrobial susceptibility testing
The antimicrobial susceptibility testing was 
performed by disc diffusion method on Muller–Hinton 
agar plates supplemented with 5% defibrinated sheep 
blood4 according to the Clinical Laboratory Standards 
Institute (CLSI). The antimicrobial drug discs included 
penicillin G (β-lactam), gentamicin (aminoglycoside), 
tetracycline (tetracycline), erythromycin (macrolide), 
kanamycin (aminoglycoside) clindamycin (lincos-
amide), vancomycin (glycopeptide), chloramphenicol 
(amphenicol), ofloxacin (fluoroquinolone) and cipro-
floxacin (fluoroquinolone). After incubation at 37oC 
for 18-24 h, the strains could be determined as sensi-
tive, intermediate (reduced susceptibility) or resistant 
characteristic by measuring the zone of inhibition 
according to the CLSI guidelines. We also determined 
the antimicrobial susceptibility of β-hemolytic and 
non-β-hemolytic Streptococcus agalactiae strains ac-
cording to Clinical and Laboratory Standards Institute 
(CLSI 2014).
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Detection of antimicrobial resistance genes and virulence 
genes
The antimicrobial resistance and virulence 
genes of strains were detected by conventional PCR 
as described previously [2,7,16]. The primers used 
for PCR amplification and sequence were shown in 
supplementary material.
Statistical analysis
SPSS 21.0 was used to analyze the associations 
between phenotypic and genotypic resistance pat-




Out of 1,122 clinical mastitis milk samples 
collected and processed, 87.4% (n= 981) were culture 
positive for bacteria. A total of 1,235 bacterial isolates 
were obtained and the distribution of bacterial species 
was shown in Table 1.
Table 1. The distribution of bacterial and fungal species.
Pathogen Number Proportion (%)
Streptococcus agalactiae 324 26.2
Escherichia coli 287 23.2
Staphylococcus aureus 131 10.6
Staphylococcus epidermidis 95 7.7
Streptococcus lactis 80 6.5
Enterococcus faecalis 78 6.3
Streptococcus uberis 52 4.2
Enterococcus faecium 47 3.8
Streptococcus dysgalactiae 19 1.5
Klebsiella sp. 18 1.5
Lactococcus lactis subsp. 15 1.2
Pseudomonas aeruginosa 7 0.6
Moulds 7 0.6
 Streptococcus parauberis 6 0.5
Shigella 6 0.5
Lactococcus garvieae 5 0.4
Yeasts 5 0.4
Citrobacter 5 0.4
Streptococcus pyogenes 4 0.3
Acinetobacter sp. 3 0.2
Arcanobacterium pyogenes 2 0.2
Proteus sp. 2 0.2
Undetected 37 3.0
Total 1235 100
Hemolytic characteristic and capsular serotypes
From the 81 isolates analyzed, only three se-
rotypes were identified: Ia (44 %), II (53.6%) and VII 
(1.2%) as shown in Table 2. In addition, we found that 
the serotypes (Ia and II) and β-hemolytic have a sig-
nificant correlation (P < 0.01) by Chi-square analysis.
Table 2. The result of serotypes and hemolysis of Streptococcus agalactiae.
Serotype
The type of hemolytic
Total
β-hemolytic Non-β-hemolytic
Ia 40 1 41
II 2 37 39
VII 1 0 1
Total 43 38 81
Antimicrobial susceptibility 
The antimicrobial resistances of Streptococcus 
agalactiae cultured from bovine mastitis were shown 
in Table 3. Most of them were resistant to kanamycin 
(93.8%). In addition, we found that 96.3% of strains 
were resistant to at least one of the antibiotics tested.
Detection of antimicrobial resistance genes
The presence of antibiotic resistance genes 
was studied by PCR in all Streptococcus agalactiae 
strains as shown in Table 4. The relationship between 
the antimicrobial resistance and corresponding genes 
were also analysed in this study. As show in Table 5, 
we found the susceptibility to erythromycin and gene 
ermA have a significant interaction (P < 0.05), the 
susceptibility to tetracycline and tetK, tetM, tetO have 
a strongly significant interaction (P < 0.01).
Detection of virulence-related genes
The presence of nine virulence-related genes 
was tested by PCR. The gene cyl was present in all 
Streptococcus agalactiae isolates. The incidence of 
cfb, hylB, scpB, glnA, scaA were 98.8%, 98.8%, 81.4%, 
76.6% and 69.1%, respectively.
DISCUSSION
Isolation and identification of mastitis pathogens
Pathogens as a cause of mastitis have become 
the major concern to the dairy industry worldwide due to 
huge economic losses. In the present study, Streptococcus 
agalactiae, Escherichia coli and Staphylococcus aureus 
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n % n % n %
Penicillin 0 0 0 0 81 100
Kanamycin 76 93.8 4 4.9 1 1.2
Gentamicin 40 49.4 29 35.8 12 14.8
Ofloxacin 4 4.9 10 12.3 67 82.7
Ciprofloxacin 9 11.1 27 33.3 45 55.6
Chloramphenicol 4 4.9 15 18.5 62 76.5
Erythromycin 26 32.1 2 2.5 53 65.4
Tetracycline 29 35.8 10 12.3 42 51.9
Clindamycin 28 34.6 0 0 53 65.4
Vancomycin 40 49.4 0 0 41 50.6
* R: resistant; I: intermediate; S: sensitive. The same as below.
Table 4. Distribution of antibiotic-resistance genes among Streptococcus agalactiae.










Table 5. Comparison of phenotypic and genotypic test for antimicrobial resistance.
Antimicrobials Gene(s)
Characteristics of Streptococcus agalactiae*
P value
P+/G+ (n) P–/G–(n) P+/G–(n) P–/G+ (n) G+(%)
Erythromycin
ermA 20 22 23 6 79.2% 0.032
ermB 24 10 45 2 94.3% 0.214
ermC 1 53 2 25 1.9% 0.963
mefA 0 26 0 55 0 --
Tetracycline
tetK 20 41 12 9 69.0% <0.001
tetL 0 53 0 29 0 --
tetM 22 51 2 7 75.9% <0.001
tetO 18 47 6 11 62.1% <0.001
tetS 12 33 20 27 41.4% 0.797
*P+: phenotypic resistance, P–: phenotypic susceptibility, G+: resistant gene positive, G–: resistant gene negative.
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were the pathogens isolated most frequently from clini-
cal mastitis. The same results were shown in previous 
reports [20,33,35]. Zhang et al. [36] observed that S. 
agalactiae was the bacterium isolated most frequently 
(38.6%) from milk samples of mastitis cases in China, 
the result was similar with our date (26.2%). In some 
other countries, the isolation rate of S. agalactiae has 
been reported to be 60% in Brazil and 42% in Colombia 
[8,23], while lower isolation rate was found in Dan-
ish (7%) and Ragusa (2%) [14,21]. In this study, the 
proportions of E. coli and S. aureus were 23.3% and 
10.6%, respectively. The same results were shown in 
an Estonia study, where E. coli (15.9%) and S. aureus 
(11.7%) were the pathogens isolated most commonly 
from case of clinical mastitis [21,26]. However, the 
results were different to previous reports where E. 
coli (7%) and S. aureus (74%) [20]. The prevalence 
of dominant mastitis pathogens differs considerably 
among countries. Even in the same country, it is always 
different among regions due to different management 
level and climate.
Capsular serotypes and haemolytic characteristic
In the case of Streptococcus agalactiae, we per-
formed additional molecular serotyping of the isolated 
strains. Such investigations are extremely important 
considering both epidemiology and prophylaxis, as 
they may aid the development of multivalent vaccines 
containing capsular polysaccharides [35]. Several 
methods have been used to investigate the serotyping 
of S. agalactiae. Among them, capsular serotyping is 
a classical method used for S. agalactiae in epidemio-
logical studies. To date, ten serotypes, based on the S. 
agalactiae capsular polysaccharides (cps), have been 
identified, including Ia, Ib, II-VIII and a new serotype 
IX [4,18]. In the present study, serotype II (53.6%), Ia 
(44 %) and VII (1.2%) were detected from S. agalactiae 
strains isolated from clinical cows with mastitis [35], our 
finding are coincident with the previously reported data, 
but the prevalence of the each serotype was variable and 
we also identified one serotype VII. Indeed, the data of 
serotype distribution of S. agalactiae associated with 
bovine mastitis have revealed considerable variation in 
the distinct geographical areas. Serotype Ia, Ⅱ, Ⅱ, IV 
and V reported previously were the most prevalent in 
the Brazil, Canada and Norway, respectively [28,30,37]. 
In the present study, we also identified hae-
molytic characteristic of all S. agalactiae strains. We 
concluded that serotypes (Ia and II) and β-hemolytic 
have significant correlation (P < 0.01) in all isolated 
strains. We made an assumption that either in processes 
of capsular and haemolytic appearance effected the 
expression of another. The unclear mechanism remains 
to be resolved in the future.
Phenotypic and genotypic resistance
The present study showed that 81 Streptococ-
cus agalactiae isolates tested against 10 antibiotics 
demonstrated the existence of a variable and broad 
antimicrobial resistance profile among local S. aga-
lactiae. Penicillin was recommended as a preferred 
antibiotic for the treatment of both human and bovine 
S. agalactiae infection. Our data showed that all strains 
were susceptibility to penicillin which was in agreement 
with the previously reported data about the high levels 
of susceptibility to penicillin of mastitis S. agalactiae 
[12,24,31]. But one study from Inner Mongolia, China, 
reported penicillin resistant S. agalactiae, despite of de-
creased susceptibility to penicillin, it is still a preferred 
antibiotic used for treatment of S. agalactiae mastitis 
in China [7].
Erythromycin and clindamycin are recom-
mended for penicillin-allergic individuals. How-
ever, because of extensive use of erythromycin and 
clindamycin, the rate of strains which were resistant 
to erythromycin have been described in Brazil from 
10.5% between 1987 and 1988 to 60% between 2003 
and 2006 [28]. In the present study, resistance to eryth-
romycin and clindamycin were observed in 32% and 
34.6% of our strains, respectively. This result is lower 
than those reported in Inner Mongolia, China [7].
Erythromycin and clindamycin belong to 
antimicrobial categories of macrolides and lincos-
amides, respectively. The products of erm genes confer 
combined resistance to macrolides and lincosamides 
by methylation of the ribosomal binding site of these 
drugs [4,11] and the mef gene is another major resis-
tant factor of resistance to erythromycin. We detected 
the related genes ermA (53.1%), ermB (85.2%), ermC 
(3.7%) in all strains, while the strains of resistance to 
erythromycin harbored genes ermA (79.2%), ermB 
(94.3%), ermC (1.9%), respectively. None of the 
tested strains were positive for mefA. The results in-
dicated that the ermB gene was most frequent among 
the erythromycin-resistant S. agalactiae, which is in 
accordance with other studies [11,28]. However, we 
found that the susceptibility to erythromycin and gene 
ermA have a significant interaction, while susceptibility 
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to erythromycin and gene ermB have a not significant 
interaction by analyzing the relationship of phenotypic 
and genotypic resistance.
Tetracycline is one of the main antimicrobi-
als in the prevention and control of bovine mastitis 
[22,34]. Because of the vast and irrational use of tet-
racycline, the rate of tetracycline-resistant strains has 
been increased. Some reports have showed that the rate 
of tetracycline-resistant S. agalactiae from cattle was 
considerably higher than previous data in Brazil and 
in the United States [28]. Our result showed that the 
rate of tetracycline-resistant strains was 35.8%, which 
was much lower than described (61.7%) previously in 
Inner Mongolia, China [7]. Resistance to tetracycline is 
usually mediated either by active efflux of tetracycline 
from the cell (tetL and tetK) or by ribosomal protection 
(tetM, tetO, tetS, and tetT) from the action of tetracy-
cline. In this present study, the genes tetK, tetM, tetO 
and tetS were harbored in 39.5%, 29.6%, 29.6% and 
39.5% of all strains respectively, while no gene tetL 
was detected. The tetracycline-resistant strains carried 
at least one tet gene. The result was in accordance with 
previous report [7]. After analyzing the susceptibil-
ity to tetracycline and genes tet, the result indicated 
resistance to tetracycline was attributed to the genes 
tetK, tetM or tetO (P < 0.01) which are in according to 
previous study of Staphylococcus aureus [35].
In this study, all strains had a high frequency 
of phenotypic resistance to kanamycin (98.8%) and 
gentamicin (85.2%), which belonged to aminogly-
cosides. The rate of non-sensitive isolates from the 
mastitis milk of dairy cows were 54.8% (kanamycin) 
and 16.1% (gentamicin) in Shahrekord district, Iran [9]. 
In another study the rate of gentamicin-non-sensitive 
Streptococcus agalactiae isolates from bovine mastitis 
cases was 76.9% in Michigan [12]. In the contrast, the 
percentage of the gentamicin-resistance isolates from 
cases of bovine subclinical mastitis was found in 3.7% 
in India [19]. 
In addition, phenotypic resistance to partial 
pairs antibiotic agents have significant interaction. 
Excepting the antibiotic agents belonged to the same 
categories or antibiotic agents had the same resistant 
mechanisms, the mechanisms need to further study in 
the pairs antibiotic agents with significant interaction.
Virulence genes
The severity of Streptococcus agalactiae infec-
tions may be determined by various virulence factors. 
Surface enzyme ScpB, a C5a peptidase, encode by scpB 
gene, could promote bacterial invasion of epithelial cells 
by attenuating recruitment of polymorphonuclear leuko-
cytes to the site of infection [3,19]. In the present study, 
the scpB gene was found in 81.4% of all strains. The 
result was similar to the previous reported strains from 
human in Kuwait [10], while lower prevalence data was 
found in bovine strains in India and in Inner Mongolia, 
China [16,35]. Some reports showed the gene scpB 
was found more frequent in human than in bovine [10]. 
However, our result was not in accordance with these 
findings. The gene cfb encodes forceramide-binding 
protein. According to the studies of Shome et al. [33], 
all S. agalactiae isolates carried the cfb gene, the result 
was similar with our date. The genes cyl and hylB encode 
for b-hemolysin and group B Streptococcal hyaluronate 
lyase, respectively. In the present study, 100% isolates 
had the cyl gene, 98.8% isolates had the hylB gene. Ding 
et al. [7] reported that cyl and hylB were founded to be 
48.1% and 49.4%, while Eskandarian et al. [13] reported 
that cylE and hylB were found in 97.1% and 94.2% in 
human strains, respectively. The gene lmb, bac, and bca 
code laminin binding protein, β-C protein, α-C protein 
respectively. Our result showed 24.7%, 12.3%, 49.3% 
strains of all harbored lmb, bac, and bca, respectively. 
These observations are in agreement with earlier reports 
[7]. The results suggested the cyl, cfb, hylB and scpB 
genes may play an important role in the virulence of S. 
agalactiae pathogens.
CONCLUSIONS
This study showed that a relatively high 
number of isolates of Streptococcus agalactiae was 
cultured from milk samples of bovine clinical mas-
titis in China. The serotypeⅠa and serotypeⅠ were the 
predominant serotypes in the S. agalactiae strains 
isolated from cases of bovine mastitis. The serotype 
distribution of the S. agalactiae strains could provide 
the basis for developing the bovine mastitis vaccine. 
Besides, our study demonstrated that S. agalactiae 
from bovine mastitis in China are resistant to many 
of the antimicrobial compounds commonly used for 
treatment of mastitis. Resistance to erythromycin was 
attributed to the genes ermA (P < 0.05) and resistance 
to tetracycline was attributed to the genes tetK, tetM, 
tetO (P < 0.01). In addition, the results indicated that 
the virulence genes cyl, cfb, hylB were preponderant 
virulence genes in S. agalactiae.
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